News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|April 5, 2022

Dr. Amy Paller discusses long-term safety and efficacy of ixekizumab in kids

Author(s)Miranda Hester

Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Dr. Paller discusses the findings of the clinical trial discussing the long-term effects of ixekizumab for treating psoriasis in children.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA expands indication for MED-EL cochlear implants to infants 7 months and older | Image credit: Contemporary Pediatrics

FDA expands indication for MED-EL cochlear implants to infants 7 months or older

ByMorgan Ebert, Managing Editor

December 4th 2025

New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants | Image Credit: © Sukjai Photo - stock.adobe.com.

New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants

ByMorgan Ebert, Managing Editor

December 3rd 2025

FDA news in pediatrics: November 2025 | Image credit: Contemporary Pediatrics

FDA news in pediatrics: November 2025

ByJoshua Fitch, Senior Editor ,Morgan Ebert, Managing Editor

December 2nd 2025

First patient dosed in trial of EN-374 to treat X-linked chronic granulomatous disease | Image Credit: © Dzmitry - © Dzmitry - stock.adobe.com.

First patient dosed in trial of EN-374 to treat X-linked chronic granulomatous disease

ByJoshua Fitch, Senior Editor

December 1st 2025

Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia | Image Credit: © ktsdesign - stock.adobe.com.

Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia

ByMorgan Ebert, Managing Editor

November 29th 2025

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

ACIP votes to update hepatitis B vaccine recommendation for infants

New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants

Hepatitis B Foundation president discusses recommendations for infant vaccination

ACIP delays vote on hepatitis B virus vaccine to December 5

Christine Eng, MD, on addressing barriers to exome and genome sequencing in clinical practice

© 2025 MJH Life Sciences^®

All rights reserved.